Endovascular

Case 3: High Risk Intermediate PE With Iliocaval DVT

33 min.

Case 2: Neurosurgical Patient With High Risk Intermediate PE

27 min.

Case 1: Massive PE With Shock

30 min.

tate of the Art Lecture: PE New Devices and Catheters: What Will Be New in 2024?

13 min.

Catheter Interventions for Pulmonary Embolism: Clinical Trial Update

10 min.

Modeling the RV Through HARVI

20 min.

Advances in RV Assessment Through TTE

10 min.

New Risk Stratification Tools: AI, Biomarkers, Invasive Hemodynamics, etc.

10 min.

What Skills Are Needed to Start a Balloon Pulmonary Angioplasty Program?

9 min.

Institutional Multidisciplinary Approach to Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

13 min.

How to Establish an Effective Post-PE Pathway

8 min.

Complications With Catheter Therapy

17 min.

Catheter Thrombectomy 101: Tips, Tricks, and Pitfalls, Small Bore and Large Bore

8 min.

Why Should a Cardiologist Care About Pulmonary Embolism?

9 min.

Catheter-Directed Thrombolysis: Protocols, Duration, etc

8 min.

Invasive Hemodynamic Assessment in the Pulmonary Embolism

11 min.

Debate: Intermediate-Risk Pulmonary Embolism — No Data for Catheters, Stick With Heparin!

8 min.

Debate: Intermediate-Risk Pulmonary Embolism – Catheter Thrombectomy Is Best

7 min.

Debate: Intermediate-Risk Pulmonary Embolism – Catheter-directed Thrombolysis as the Primary Option

9 min.

Debate: High-risk Pulmonary Embolism – Surgery Is the Way

14 min.

Debate: High-risk Pulmonary Embolism – Catheter Therapy First in the Modern Era

8 min.

Debate: High-risk Pulmonary Embolism – Systemic Thrombolysis Is Still the Gold Standard

8 min.

PE Risk Stratification in 2023

11 min.

Keynote Lecture: Advances in Interventional Treatment of Pulmonary and Right Heart Thrombosis

14 min.

Intelligent Interventions: Personalized Medicine for VTEs (FlowMedical)

11 min.

PFO PRIMER: Updates and Spotlights – Technology and Techniques: Difficult Cases

6 min.

Real World Experience of Contemporary Pulmonary Embolism Treatment (USCDT versus MT): Insights From Big Data Analytics (REAL-PE)

18 min.

Pulmonary Artery Denervation: Innovative Pulmonary Hypertension Therapies

9 min.

BPA in CTEPH Management

10 min.

Catheter-Based Management of Infectious Endocarditis

8 min.

CTEPH? CTED? How Do We Make the Diagnosis?

9 min.

Anticoagulation for PE: When to Switch to DOACs?

6 min.

Getting Smart With PE Diagnosis: The Role of AI

8 min.

The PERT Effect: How to Establish a Multdisciplinary Care Team for PE

8 min.

State-of-the-Art Lecture: Future Device Therapies in PE

12 min.

What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE?

10 min.

Large Bore Thrombectomy: Are We Any Closer to Understanding Which Device Is Best?

10 min.

Catheter Directed Thrombolysis: New Devices, Drugs, and Duration?

10 min.

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Intro

2 min.

Massive PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Conclusion

3 min.

TCT 694: Debulking Tricuspid Valve Vegetations: Using AngioVac to Avoid Reoperations for Prosthetic Valve Endocarditis

6 min.

Iliocaval Stenting and Reconstructions With Extreme Case Examples

12 min.

R Sided Clot in Transit

9 min.

BPA for CTEPH: When and How?

10 min.

Anticoagulation Strategies in High-Risk PE: Are DOACs Enough? When Do We Switch?

8 min.

Is There a Role for MCS in Massive PE and Which Modality?

8 min.

Surgical Embolectomy Is the Way to Go in High-Risk PE

7 min.

Who Gets Systemic Thrombolysis Anymore?

9 min.

High-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Introduction

2 min.

Aspiration Thrombectomy: a Potential Treatment for Pulmonary Embolism in COVID-19

5 min.

The immediate change in cardiac and hemodynamic physiology following catheter-directed alleviation of intermediate high-risk pulmonary embolism

5 min.

FlowTriever Thrombectomy for “Intermediate Risk” Pulmonary Embolism in a Jehovah’s Witness Patient

5 min.

Case : Emergent thrombectomy in PE with shock

5 min.

Innovation in Interventional PE Therapies

9 min.

Case 2: COVID Patient With Clot in Transit

7 min.

Case 1: Catastrophic PE With Shock

7 min.

Catheter-Based Thrombus Extraction Using Electro-Magnetic Fields (Magneto eTrieve™)

7 min.